EcoR1 Panacea Holdings, LLC insider trades: Nuvation Bio (NUVB) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where EcoR1 Panacea Holdings, LLC reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 13, 2021 | NUVB | ↑ Buy | 406,019 | $9.89 | $4.0M | See Notes 1 and 2 | Apr 13, 2021 (0d) |
| Apr 13, 2021 | NUVB | ↑ Buy | 58,481 | $9.89 | $578K | See Notes 1 and 3 | Apr 13, 2021 (0d) |
| Jul 6, 2020 | PANA | ↑ Buy | 390,000 | $10.00 | $3.9M | Direct | Jul 6, 2020 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NUVB insiders
Open-market trades in the last 12 months
About EcoR1 Panacea Holdings, LLC's insider trades
EcoR1 Panacea Holdings, LLC is a 10% owner of Nuvation Bio (NUVB). Since Jul 6, 2020, it has reported 3 open-market purchases worth $8.5M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include grants and awards (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NUVB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.